Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma

Journal of Drug Targeting

Volumn 3, Issue 5, 1996, Pages 385-390

  Pimm, Malcolm V ^a   Perkins, Alan C ^b   Strohalm, Jiri ^c   Ulbrich, Karel ^c   Duncan, Ruth ^d,e  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^d KEELE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Gamma camera imaging; N (hydroxypropyl)methacrylamide copolymers; Polymeric drug carriers

Indexed keywords

COPOLYMER; DOXORUBICIN; DRUG CARRIER; GALACTOSAMINE; IODINE 123; N (2 HYDROXYPROPYL)METHACRYLAMIDE; ANTINEOPLASTIC ANTIBIOTIC; HYDROXYPROPYL METHACRYLATE; METHACRYLIC ACID DERIVATIVE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; GAMMA SCINTIGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BINDING SITE; CANCER TRANSPLANTATION; CARCINOMA; CELL CULTURE; COLON TUMOR; DRUG DELIVERY SYSTEM; GAMMA RADIATION; LIVER TUMOR; METABOLISM; NUDE MOUSE; SCINTISCANNING; ULTRASTRUCTURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BINDING SITES; CARCINOMA; COLONIC NEOPLASMS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GALACTOSAMINE; GAMMA RAYS; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; ISOTOPE LABELING; LIVER NEOPLASMS; METHACRYLATES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIONUCLIDE IMAGING; TUMOR CELLS, CULTURED;

EID: 0029662276     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869608996829     Document Type: Article

References (22)

1. Ashwell, G. and Morell, A.G. (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins, Adv. in Enzymol., 41, 99-128.
2. Cassidy, J., Duncan, R., Morrison, G.J., Strohalm, J., Plocova, D., Kopecek, J. and Kaye, S.B. (1989) Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. Biochem. Pharmacol, 38, 875-879.
3. Chytry, V., Kopecek, J., Leibnitz, E, O'Hare, K., Scarlett, L. and Duncan, R. (1987). Copolymers of 6-o-methacryloyl-D-galactose and N-(2-hydroxypropyl)methacrylamide: Targeting to liver after intravenous administration to rats. New Polymeric Mat., 1, 21-28.
4. Duncan, R., Cable, H.C., Lloyd, J.B., Rejmanova, P. and Kopecek, J. (1983a) Degradation of side-chains of N-(2-hydroxypropyl) methacrylamide copolymers by lysosomal thiol-proteinases, Bioscience Reps, 2, 1041-1046.
5. Duncan, R., Kopecek, J., Rejmanova, P. and Lloyd, J.B. (1983b) Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues, Biochim. Biophys. Acta, 755, 518-521.
6. Duncan, R., Seymour, L.C.W., Scarlett, L., Lloyd, J.B., Rejmanova, P. and Kopecek, J. (1986) N-(2-Hydroxypropyl)methacrylamide copolymers with pendant galactosamine residues. Fate after intravenous administration to rats, Biochim. Biophys. Acta, 880, 62-71.
7. Duncan, R. (1992) Drug-polymer conjugates : potential for improved chemotherapy. Anti-Cancer Drugs, 3, 175-210.
8. Duncan, R., Seymour, L.W., O'Hare, K.B., Flanagan, P.A., Wedge, S., Ulbrich, K., Strohalm, J., Subr, V., Spreafico, F., Grandi, M., Ripamonti, M., Farao, M., Suarato, A. (1992) Preclinical evaluation of polymer-bound doxorubicin, J. Controlled Rel., 19, 331-346.
9. Duncan, R., Vasey, PA., Kaye, SB. and Cassidy, J. (1995). Development of PK1, an HPMA copolymer doxorubicin conjugate. The CRC experience. Abstract from the EORTC Early Drug Development Meeting, Corfu June 22-24, pp 60-61.
10. 2 mice and activity of conjugates containing daunomycin against L1210 leukaemia in vivo. J. Controlled Release, 18, 25-38.
11. Kopecek, J., Rejmanova, P., Chytry, V. (1981). Polymers containing enzymatically degradable bonds. 1. Chymotrypsin catalyzed hydrolysis of p-nitroanilides of phenylalanine and tyrosine attached to side-chains of copolymers of N-(2-hydroxyppropyl)-methacrylamide. Makromol. Chem., 182, 799-809.
12. O'Hare, K.B., Hume, I.C., Scarlett, L and Duncan, R. (1989) Evaluation of anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. Effect of galactose incorporation on interaction with hepatoma in vitro, Hepalology, 10, 207-214.
13. O'Hare, K.B., Duncan, R., Strohalm, J., Kopeckova, P., Kopecek, J. and Ulbrich, K. (1993) Macromolecular prodrugs containing doxorubicin and melanocyte stimulating hormone in vitro and in vivo evaluation against murine melanoma, J. Drug Targeting 1, 217-230
14. Pimm, M.V., Perkins, A.C., Duncan, R., and Ulbrich, K. (1993) Targeting of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate to the hepatocyte galactose-receptor in mice: Visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studies. J. Drug Targeting, 1, 125-131.
15. 123I. Nucl. Med Commun., 7, 355-362.
16. Rejmanova, P., Kopecek, J., Pohl, J., Baudys, M., Kostka, V. (1983) Polymers containing enzymatically degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers by bovine spleen cathepsin B. Makromol. Chem., 184, 2009-2020.
17. Rihova, B., Bilej, M., Vetvicka, V., Ulbrich, K., Strohalm, J., Kopecek, J., and Duncan, R. (1989). Biocompatibility of N-2-hydroxypropyl-methacrylamide copolymers containing adriamycin. Biomaterials, 10, 335-342.
18. Seymour, L.W, Ulbrich, K., Strohalm, J. and Duncan, R. (1991) Pharmacokinetics of a polymeric drug carrier targeted to the hepatocyte galactose receptor. Brit. J. Cancer, 63, 859-866.
19. Seymour, L.W., Ulbrich, K., Styger, P.S., Brereton, M., Subr V, Strohalm, J. and Duncan R. (1994) Tumouritropism and anticancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma. Br. J. Cancer, 70, 636-641.
20. Virgolini, L, Muller, C., Klepetko, W., Angelberger, P., Bergmann, H., O'Grady, J., and Sinzinger, H. (1990) Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand. Br. J. Cancer, 61, 937-941.
21. Yeung, T.K., Hopewell, J.W., Rezzani, G., Simmonds, R.H., Seymour, L.W., Duncan, R., Bellini, O., Grandi, M. (1991) Spreafico, F., Strohalm, J. and Ulbrich, K., Reduced cardiotoxicity of doxorubicin administered in the form of N-(2-hydroxypropyl)methacrylamide conjugates: an experimental study in the rat. Cancer Chemother. Pharmacol., 29, 105-111.
22. Watson S.A., Morris, T.M, Crosbee, D.M. and Hardcastle, J.D. (1993) A hepatic invasive human colorectal xenograft model. Eur. J. Cancer., 29A, 1740-1745.